Target intelligence / Profile preview

RN7SK pseudogene 217 (RN7SKP217)

Target
RN7SKP217
Molecular classification
Other (noncoding RNA pseudogene)
01

Overview

RN7SK pseudogene 217 refers to a specific member of the RN7SK pseudogene family. These are nonfunctional genomic sequences derived from the ancestral 7SK small nuclear RNA (snRNA) gene. The canonical 7SK snRNA is an abundant, highly conserved noncoding RNA that regulates eukaryotic transcription by controlling the activity of positive transcription elongation factor b (P-TEFb), participating in cell growth, proliferation, differentiation, and certain disease states[2][3][1]. However, "RN7SKP217" is a pseudogene variant, meaning it does not produce a functional RNA or protein product and has no known role in cellular processes or disease. There are numerous RN7SK pseudogenes in the human genome, and most are not transcribed or functionally characterized. The functional 7SK snRNA acts as a scaffold for ribonucleoprotein complexes controlling transcription elongation and is relevant in neural differentiation, cancer, and viral infection[1][2][3]. Pseudogenes like RN7SKP217 are genomic elements lacking promoter activity or harboring disruptive mutations that prevent them from being transcribed or functional, though rare exceptions exist where pseudogenes gain regulatory or pathological significance. There is no evidence that RN7SKP217 is active or relevant in this way. RN7SKP217 should not be listed as a therapeutic target, biomarker, or functional receptor. If the intent was to refer to the functional 7SK small nuclear RNA (7SK snRNA), refer to "7SK small nuclear RNA (7SK snRNA)" or "RNA, 7SK" and not a pseudogene designation[2][3][1].

Other names
RN7SKP217
02

Biological functions

None (as a pseudogene, it lacks known biological function)
03

Disease associations

None established (no evidence of involvement in disease as a pseudogene)

Beyond the preview

Go deeper on RN7SK pseudogene 217 (RN7SKP217).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 217 (RN7SKP217).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call